Redhill Biopharma Ltd.
SEC CIK 1553846 · RDHL · last insider filing 2026-04-22
Directors (from insider filings)
| Name | Capacity as filed | Filings |
|---|---|---|
| Tsimchi Ofer | Director | filed 2026 - 2026 |
| Scruggs Rick D | Director · Chief Commercial Officer | filed 2026 - 2026 |
| Ben-Asher Dror | Director · Chief Executive Officer | filed 2026 - 2026 |
| Cabilly Shmuel | Director | filed 2026 - 2026 |
| Reed Kenneth | Director | filed 2026 - 2026 |
| Mamluk Roni | Director | filed 2026 - 2026 |
Officers (from insider filings)
| Name | Title as filed | Filings |
|---|---|---|
| Raday Gilead | Chief Operating Officer | filed 2026 - 2026 |
| Frish Adi | Chief Corp & BD Officer | filed 2026 - 2026 |
| Ingber Razi | Chief Financial Officer | filed 2026 - 2026 |
| Goldberg Guy Joel | Chief Business Officer | filed 2026 - 2026 |
About this record
From the SEC's insider-transaction filings (Forms 3, 4 and 5). Every reporting director and officer carries a Commission-assigned identifier (CIK), so these footprints are identifier-verified - no name matching involved. Insiders file when they transact, so dates are filing dates: "last filed" never means "served until". This layer is not yet joined to the nonprofit register - identity joins ship only after independent review.
Source: SEC Insider Transactions Data Sets (Forms 3/4/5), US Federal Government public domain.